Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
The American Journal of Cardiology
|
June 21, 2006
Reasons for escalating pacemaker implants
David Birnie, Kathryn Williams, Ann Guo, et al.
Heart Rhythm
|
December 5, 2009
Effect of lateral wall scar on reverse remodeling with cardiac resynchronization therapy
David Birnie, Rob A DeKemp, Terence D Ruddy, et al.
The Canadian Journal of Cardiology
|
May 14, 2013
Identification of inflamed aortic plaque in conventional fluorodeoxyglucose-positron emission tomography myocardial viability studies
Yingwei Liu, Nina Ghosh, Girish Dwivedi, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 14, 2011
Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy
David Birnie, Rob A de Kemp, Anthony S Tang, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
April 14, 2018
Prognostic utility of splenic response ratio in dipyridamole PET myocardial perfusion imaging
Karan Bami, Shrankhala Tewari, Fadi Guirguis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 19, 2010
18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial
Arun Abraham, Graham Nichol, Kathryn A Williams, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
March 15, 2012
Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease?
Maria C Ziadi, Robert A Dekemp, Kathryn Williams, et al.
Journal of the American College of Cardiology
|
August 6, 2011
Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia
Maria C Ziadi, Robert A Dekemp, Kathryn A Williams, et al.
Circulation. Heart Failure
|
July 15, 2016
Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction
Kajenny Srivaratharajah, Thais Coutinho, Robert deKemp, et al.
Journal of the American College of Cardiology
|
November 13, 2007
F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2)
Rob S B Beanlands, Graham Nichol, Ella Huszti, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
The American Journal of Cardiology
|
June 21, 2006
Reasons for escalating pacemaker implants
David Birnie, Kathryn Williams, Ann Guo, et al.
Heart Rhythm
|
December 5, 2009
Effect of lateral wall scar on reverse remodeling with cardiac resynchronization therapy
David Birnie, Rob A DeKemp, Terence D Ruddy, et al.
The Canadian Journal of Cardiology
|
May 14, 2013
Identification of inflamed aortic plaque in conventional fluorodeoxyglucose-positron emission tomography myocardial viability studies
Yingwei Liu, Nina Ghosh, Girish Dwivedi, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 14, 2011
Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy
David Birnie, Rob A de Kemp, Anthony S Tang, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
April 14, 2018
Prognostic utility of splenic response ratio in dipyridamole PET myocardial perfusion imaging
Karan Bami, Shrankhala Tewari, Fadi Guirguis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 19, 2010
18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial
Arun Abraham, Graham Nichol, Kathryn A Williams, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
March 15, 2012
Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease?
Maria C Ziadi, Robert A Dekemp, Kathryn Williams, et al.
Journal of the American College of Cardiology
|
August 6, 2011
Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia
Maria C Ziadi, Robert A Dekemp, Kathryn A Williams, et al.
Circulation. Heart Failure
|
July 15, 2016
Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction
Kajenny Srivaratharajah, Thais Coutinho, Robert deKemp, et al.
Journal of the American College of Cardiology
|
November 13, 2007
F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2)
Rob S B Beanlands, Graham Nichol, Ella Huszti, et al.
Page
of 2